Personal CFO Solutions’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495K | Buy |
12,900
+523
| +4% | +$20.1K | 0.09% | 228 |
|
|
2025
Q1 | $479K | Buy |
12,377
+653
| +6% | +$25.3K | 0.1% | 217 |
|
|
2024
Q4 | $397K | Buy |
11,724
+626
| +6% | +$21.2K | 0.08% | 246 |
|
|
2024
Q3 | $454K | Buy |
11,098
+629
| +6% | +$25.7K | 0.06% | 288 |
|
|
2024
Q2 | $403K | Sell |
10,469
-48
| -0.5% | -$1.85K | 0.06% | 298 |
|
|
2024
Q1 | $451K | Buy |
10,517
+430
| +4% | +$18.4K | 0.07% | 280 |
|
|
2023
Q4 | $374K | Buy |
10,087
+263
| +3% | +$9.75K | 0.06% | 313 |
|
|
2023
Q3 | $356K | Buy |
9,824
+1,255
| +15% | +$45.5K | 0.07% | 283 |
|
|
2023
Q2 | $305K | Buy |
8,569
+1,456
| +20% | +$51.9K | 0.06% | 326 |
|
|
2023
Q1 | $253K | Buy |
7,113
+1,087
| +18% | +$38.7K | 0.05% | 364 |
|
|
2022
Q4 | $212K | Buy |
+6,026
| New | +$212K | 0.04% | 408 |
|
|
2022
Q3 | – | Sell |
-4,161
| Closed | -$226K | – | 439 |
|
|
2022
Q2 | $226K | Buy |
+4,161
| New | +$226K | 0.05% | 352 |
|